Breakthrough combo: ketamine shot & online therapy tested to rapidly stop suicidal thoughts
NCT ID NCT06480500
Summary
This study is testing if a combination of intravenous ketamine and online cognitive behavioral therapy (i-CBT) can quickly and effectively reduce suicidal thoughts and behaviors in people with treatment-resistant depression. Over 13 weeks, 110 participants will all receive weekly online therapy, but half will also receive six ketamine infusions while the other half receives a control medication. The main goal is to see if the combination leads to a greater reduction in suicidality within the first month compared to therapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, Canada
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.